Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02094872
Title Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Yale University
Indications

melanoma

Therapies

Doxorubicin

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Cancer Center Scottsdale Arizona 85259-5499 United States Details
Smilow Cancer Hospital at Yale-New Haven New Haven Connecticut 06520-8028 United States Details
Mayo Clinic Cancer Center Jacksonville Florida 32224 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0944 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Mayo Clinic Cancer Center Rochester Minnesota 55905 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37240 United States Details
Baylor Sammons Cancer Center Dallas Texas 75246 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field